Aptar Q1 adjusted EPS $1.19 (-8% YoY); names Gael Touya CEO effective Sept 1

APTARGROUP, INC.

2026-Q1 EPS reported $1.12 vs consensus $1.16 ▼ miss (-3.7%)

Reported sales up 11% to $982.9M; core sales flat; net income down 8% to $73M.
Adjusted EPS $1.19 vs. $1.30; adjusted EBITDA margin 19.2% vs. 20.7%.
Pharma core sales -1% (prescription -10% on emergency medicine destocking; injectables +20%).
Beauty core sales +3%; Closures core flat; both segments saw margin compression.
Q2 2026 adjusted EPS guidance $1.32-$1.40; declared $0.48 dividend payable May 27.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

APTARGROUP, INC. reported the quarter ended March 31, 2026 results: revenue $982.9 million, net income $73 million, EPS $1.12. Guidance initiated.

Period: the quarter ended March 31, 2026
Revenue: $982.9 million
Net income: $73 million
EPS: $1.12
Guidance: initiated
Result: reported results

Exact text from the filing

fragrance and beverage applications,” said Stephan B. Tanda, Aptar President and CEO. First Quarter Results For the quarter ended March 31, 2026, reported sales increased 11% to $982.9 million compared to $887.3 million in the prior year period. Core sales were flat compared to the prior year period. First Quarter Segment Sales Analysis (Change Over Prior Year) Pharma

View on SEC.gov

1435 earnings releases filed in the last 30 days. Browse all earnings releases →

APTARGROUP, INC. filing history →

Source: SEC EDGAR

accession 0000896622-26-000090

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.